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resumo 
 
 
As histatinas pertencem a uma família de peptídeos básicos ricos em histidinas 
que se encontram na saliva humana (Oppenheim et al., 1988). As principais 
histatinas, designadas histatinas 1 e 3, são codificadas pelos genes HTN1 e 
HTN2, localizados no cromossoma 4q13 (Sabatini et al., 1993). A histatina 3 é 
submetida a uma fragmentação pré-secretória, presumivelmente pela acção de 
uma convertase furin-like, e cria pelo menos 24 diferentes histatinas menores. 
Pelo contrário, a histatina 1, um peptídeo de 38 resíduos de amino ácidos, que 
comparte largamente a sua sequência com a histatina 3, não é submetida a 
fragmentação, provavelmente devido à ausência da sequência consenso da 
convertase (Castagnola et al., 2004). A histatina 3 e alguns dos seus 
fragmentos, em particular a histatina 5, têm propriedades antifungícas e 
antimicrobianas potentes, enquanto que o papel da histatina 1 ainda não foi 
bem estabelecido. Este estudo descreve os resultados obtidos na 
caracterização estrutural dos derivados poli-fosforilados da histatina 1 
detectados por HPLC-ESI MS e MALDI-TOF-MS na saliva humana.  
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abstract 
 
Histatins belong to a family of basic histidine-rich peptides found in human 
saliva (Oppenheim et al., 1988). The major histatins, namely histatins 1 and 3, 
are codified by the genes HTN1 and HTN2, localized on chromosome 4q13 
(Sabatini et al., 1993). Histatin 3 is submitted to a pre-secretory fragmentation, 
presumably by the action of a furin-like convertase, and it generates at least 24 
different minor histatins. On the contrary, histatin 1, a peptide of 38 amino acid 
residues, largely sharing its sequence with histatin 3, is not submitted to 
fragmentation, probably due to the lack of the convertase consensus sequence 
Castagnola et al., 2004). Histatin 3 and some of its fragments, particularly 
histatin 5, show powerful antifungal and antimicrobial properties, whereas the 
role of histatin 1 has not been established. This study describes the results on 
the structural characterization of poly-phosphorylated derivatives of histatin 1 
detected by HPLC-ESI MS and MALDI-TOF-MS in human saliva.  
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
"Everything that a scientist does is a function of 
what others have done before him; the past is embodied 
in every new conception and even in the possibility 
of it being conceived at all." 
 
Sir Peter Medawar (1979) 
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INTRODUCTION 
 
Multiple Phosphorylation of Histatin 1 
 
1. Saliva 
  
Saliva is defined as a fluid present in the oral cavity, produced in and 
secreted by three pairs of major salivary glands – parotid, submandibular and 
sublingual – and numerous minor glands. Salivary gland secretion is regulated 
through the activity of the sympathetic and parasympathetic nerves to the gland, 
and their neurotransmitters (Izutsu, 1989). 
 
 
 
Figure 1 – Salivary glands (GlaxoSmithKline Consumer Healthcare). 
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Both communication and alimentation may be compromised when 
salivation is abnormal. The situation of having low salivary secretions (Sjogren’s 
syndrome) reveals difficulty on speaking, chewing, forming a food bolus, and 
swallowing. In addition, there is a rapid and substantial increase in caries and 
mucosal infection, and taste and soft tissue complaints are also more frequent 
(Fox, 1989). 
 
People who are naturally resistant to caries (regardless of fluorides and 
diet) have enhanced salivary protective mechanisms that include increased ability 
to produce base in plaque, a more effective means of bacterial aggregation and 
decreased pellicle permeability (Mandel, 1989). 
 
Nevertheless saliva science has initiated its track relatively late in the 
history of medicine. Centuries before Irwin Mandel, a professor emeritus of 
Columbia University, grand saliva researcher and an historian on this matter, 
started his work in the laboratory, physicians thought the salivary glands were 
lowly modest excretory organs - ridding the body of toxins and evil spirits from 
the brain, and for that reason they would dose patients with poisonous dichloride 
of mercury, causing saliva to pour from the mouth. Even in the last century, 
scientists only got serious with saliva well after they'd tackled other body fluids 
such as blood. Like Mandel once said, "Saliva doesn't have the drama of blood, it 
doesn't have the integrity of sweat, it doesn't have the emotional appeal of tears" 
(Mestel, 2006). But from the 1950s onward, salivary research has been marked by 
a series of changing perceptions as new techniques and technologies have 
illuminated the complexities of the secretory mechanism, salivary composition, 
and function. Saliva rapidly broadened from the idea of being simply a digestive 
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fluid composed of salts, amylase, and mucin to cover a wide spectrum of 
protective proteins with the dual responsibility of protecting both hard and soft 
tissues. 
 
As early as 1965, the use of several collecting devices to harvest the 
secretions from individual glands and the new separation techniques brought to 
very complex patterns (Mandel et al., 1965) and it became clear that the major 
amino acid in saliva was proline and, more distinctively, that proline, glycine, and 
glutamic acid in a ratio of 3:2:2 was pervasive in both parotid and submandibular 
secretions as well as in the separated anionic and cationic fractions. In time, the 
basic proline-rich glycoprotein of parotid saliva was characterized (Levine et al., 
1969) and then came full recognition of the proline-rich family of proteins, which 
dominate saliva (Oppenheim et al., 1971). 
 
The genetic polymorphism of these proteins was quickly recognized (Azen 
and Oppenheim, 1973). In turn, we were set up to the tyrosine-rich protein, 
statherin (Hay, 1973), the cysteine-rich (Shomers et al., 1982a), and the 
histidine-rich (MacKay et al., 1984; Oppenheim et al., 1986). 
 
In the 1950s and early 1960s described an acquired, essentially bacterial-
free, cuticle or pellicle on enamel that was distinct from the developmental cuticle 
(Nasmyth's membrane). During the 1960s, in vitro studies were begun on the 
adsorption of whole saliva to various forms of hydroxyapatite, including ground 
enamel (Hay, 1967). Selectivity of specific proteins, mainly anonic glycoproteins 
and phosphoproteins, was repeatedly noted. The acquired pellicle of selectively 
adsorbed proteins with a high affinity for hydroxyapatite coupled with neutral 
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lipids, glycolipids, and phospholipids forms a primitive membrane that provides a 
diffusion barrier that limits acid penetration and mineral exit as well as providing 
a lubricating film against excessive wear. Saliva in its insoluble form is as 
important to the maintenance of tissue integrity as is the parent fluid itself. 
 
One of the greatest saliva stories of the 1960s was also the identification 
and characterization of secretory IgA in the secretions. With more specific 
antisera, Tomasi and Zigelbaum (1963) showed that IgA, not IgG, predominated, 
and then Tomasi et al. (1965) showed that there was a distinct immune system 
common to all external secretions bathing mucous membrane surfaces. 
 
During the 1970s, not only were many salivary proteins identified and 
quantitated, but the structure and function of several of the protein families was 
elucidated - the isoamylases (Mayo and Carlson, 1974), statherin (Schlesinger 
and Hay, 1977), and the proline-rich proteins (PRPs) (Oppenheim et al., 1971; 
Bennick, 1977). In the 1980s, the cysteine-rich proteins (Shomers et al., 1982a-c) 
and the histidine-rich proteins (Oppenheim et al., 1986, 1988), cystatins and 
histatins, namely, were characterized. 
 
The digestive functions were seen to be secondary, rather than having a 
primary importance, mainly for preparing the food bolus for mastication, for 
swallowing, and for normal taste perception (Mandel, 1987). It became 
increasingly apparent that the multivariate mix of salivary constituents provides 
an effective set of systems for lubricating and protecting the soft and hard 
tissues.  
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Salivary mucins with their low solubility, high viscosity, elasticity, and 
adhesiveness are highly effective in helping to maintain mucous membrane 
integrity, acting to protect the soft tissues against dessication, penetration, 
ulceration, and potential carcinogens. Other salivary proteins can aid in this 
protective capacity; examples are PRPs that bind tannins, etiologic agents in 
esophageal cancer, cystatins, which are effective inhibitors of cysteine-proteases, 
and antileukoprotease, an inhibitor of elastase and cathepsin (Mandel, 1987, 
1989). 
 
The combination of the multiple host defense functions in saliva shows a 
protective repertoire that goes beyond antibacterial activity to include antifungal, 
antichlamydial, and antiviral properties as well (Mandel, 1993).  
 
 
 
 
Figure 2 – Multifunctionality of salivary families (adapted from Levine, 1993). 
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2. Salivary Peptides 
 
Based on several works, the salivary peptides are usually classified in five 
different main classes according to their intrinsic properties: proline-rich 
peptides (PRP), cystatins, defensins, statherin and histatins (Van Nieuw, 2004); 
figure 3. 
 
 
Figure 3 – RP-HPLC-MS profile of the acidic fraction from human saliva. 
 
 
2.1. Proline-Rich proteins (PRPs) 
 
PRPs, designation due to their high content of proline residues, are 
characterized in three different forms: acidic, basic and glycosilated (Hardt et al., 
2005). 
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2.2. Cystatins 
Cystatins cover five major isoforms: S, C, D, SA and SN. They are powerful 
inhibitors of cysteine peptidases such as cathepsins B, C, H and L, and have 
strong bactericidal and virucidal properties. 
 
 
2.3. Defensins 
 
The defensin family is found in plasma, wound fluid, intestine and skin of 
human. Its antibiotic, antifungal and antiviral properties are known (Amado et al., 
2005). 
 
 
2.4. Statherin 
 
Statherin is a multifunctional molecule with high affinity for calcium 
phosphate minerals such as hydroxyapatite that contributes to maintain the 
appropriate mineral solution dynamics of enamel. Jensen et al. (1991) 
characterized three isoforms of statherin: lacking one phenylalanine residue at 
the C-terminus (SV1), lacking residues 6-15 (SV2), and SV2 lacking phenylalanine 
residue at the C-terminus (SV3). Vitorino et al. (2004) proposed an additional 
statherin isoform corresponding to the loss of one aspartic acid residue at the N-
terminus. 
 
8 
Multiple Phosphorylation of Histatin 1 
 
2.5. Histidine-Rich Peptides 
 
The parotid and submandibular glands of humans secrete a family of 
small, mostly cationic, histidine-rich proteins called histatins (Oppenheim et al., 
1988). The current preferred peptide chemical information and nomenclature for 
histatins was proposed by Troxler et al. (1990). 
 
Histatins show strong antifungal activities and appear to actively 
participate in teeth remineralization processes (Edgerton, 2000). They have been 
also shown to be tannin-binding proteins in human saliva (Yan and Bennick, 
1995). Histatins 1, 3, and 5 comprise 85 to 90% of the total histatin proteins and 
are termed the major histatins. All 3 major histatins have candidicidal and 
bactericidal activity. 
 
There are two human genes recognized as responsible for the synthesis of 
histatin 1 and histatin 3, HTN1 (HIS1) and HTN2 (HIS2), respectively, localized on 
the chromosome 4, band q13 (Sabatini et al., 1989); Figure 4. 
 
 
 
Figure 4 – Localization of the genes HTN1 and HTN2. Chromosome 4, band q13 
assigned in red. 
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Histatin 1 is a phosphoprotein of 38 amino acids, with the modification on 
Ser-2, whereas histatin 3 has 32 amino acids with a very similar sequence to 
histatin 1, although not phosphorylated (Oppenheim et al., 1988). 
 
Troxler et al. (1990) identified in human saliva histatin 2, a peptide 
corresponding to the carboxyl terminal 26 residues of histatin 1, and nine 
peptides, all related to the sequence of histatin 3, named histatins 4-12. Except 
histatin 2, the other minor histatins are likely originated by proteolytic cleavages 
from histatin 3. Amongst there’s histatin 5, a major fragment present in human 
saliva at high concentration, showing a sequence identical to the first 24 amino 
acids of histatin 3. This peptide is the most potent member with respect to its 
fungicidal activity against the oral opportunistic pathogen Candida albicans 
species, with respect to all the other histatins (Xu et al., 1991). 
 
The study of Castagnola et al. (2004) allowed the detection of new histatin 
peptides: 24 peptides including, with the exception of histatin 4, all the known 
histatin 3 fragments, namely histatins 5-12, and the new peptides corresponding 
to 1-11, 1-12, 1-13, 5-13, 6-11, 6-13, 7-11, 7-12, 7-13, 14-24, 14-25 15-25, 
26-32, 28-32, 29-32 residues of histatin-3 (Figure 5). All these fragments 
showed a complex proteolytic pathway involving histatin 3. The absence of 
proteolytic activity on histatin 1 could be attributed to the lack of an amino acid 
equivalent to the Arg-25 residue of histatin 3, which appears to represent the 
first crucial cleavage site for this peptide.  
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Figure 5 – Time range enlargement (5-25 minutes) showing the approximate 
elution position of all the histatins and histatin 3 fragments detected by Castagnola et al. 
(2004). 
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3. Histatin 1 
 
Although the role of histatin 3 and some of its fragments, particularly 
histatin 5, is known as being antifungal and antimicrobial, the function of histatin 
1 has not been well established 
 
HTN1, the gene that synthesizes histatin 1, is expressed at very high level 
and is defined by 1866 cDNA clones. The gene contains 31 introns (AceView, 
2006). 
 
The sequence of histatin 1 (Figure 6) is largely shared by the sequence of 
histatin 3, but it is not submitted to fragmentation, as previously referred 
(Castagnola et al., 2004). 
 
 
 DSHEKRHHGY RRKFHEKHHS HREFPFYGDY GSNYLYDN 
Figure 6 – Sequence of amino acids residues of histatin 1. Underlined serine (S) 
stands for the phosphorylated residue.  
 
 
Recently, Onnis et al. (2005) presented in the Symposium of the Italian 
Biochemistry Society at Cagliari the results of HPLC-MS-ESI spectra of an acidic 
solution of whole saliva unveiling the presence of a combination of masses (Table 
1) consistent with the multiple phosphorylation of histatin 1. 
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Peptide Experimental average mass 
Theoretical average 
mass 
histatin 1 non-phosphorylated 4848 ± 0.8 4848.2 
histatin 1 mono-phosphorylated 4928 ± 0.8 4928.2 
histatin 1 di-phosphorylated 5008 ± 0.8 5008.2 
histatin 1 tri-phosphorylated 5088 ± 0.8 5088.2 
histatin 1 tetra-phosphorylated 5168 ± 0.8 5168.2 
histatin 1 penta-phosphorylated 5248 ± 0.8 5248.2 
Table 1 – Multiple phosphorylation of histatin 1 determined by HPLC-MS-ESI 
(Onnis et al. 2005). 
 
The presence of the multiple phosphorylations on the molecule may be a 
clear indication of the performed function. Therefore, the main purpose of this 
work is to establish the consistency of the histatin 1 multiple phosphorylation, 
and, if possible, determine the sites of phosphorylation occurrence. 
 
 
 
3.1. Phosphorylation identification strategy 
 
Protein phosphorylation is a common post-translational modification in 
both prokaryotes and eukaryots. The cellular processes in which it’s involved 
includes cell signaling, growth and metabolism. 
 
The phosphorylation of proteins is catalyzed by kinases (phosphorylation) 
and phosphatases (dephosphorylation). In eukaryotes, this modification occurs on 
serine (~90%), threonine (~10%) and tyrosine residues (~0.05%). Although the 
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tyrosine phosphorylation is less common, reversible phosphorylation on this 
residue plays an important role in signal transduction cascades. 
There are available several methods for phosphorylation detection and 
characterization. For instances, metabolic labeling of phosphorylated proteins 
with [32P] phosphate is a method by excellence for detection. However, 
subsequent sequence data must be acquired via Edman degradation or mass 
spectrometry. 
 
Major achievements have been accomplished in the field of mass 
spectrometry, namely the mild ionization techniques of MALDI and ESI, which 
have been honoured in 2002 by the Nobel Prize in chemistry. For the task of 
protein identification, nowadays MALDI and ESI ionization sources are commonly 
coupled to quadrupol, time-of-flight or ion trap for ion characterization. 
 
Usually, the proteins are cleaved with chemicals or proteases to obtain 
smaller peptide fragments. Trypsinization is the most common strategy used. The 
layout of ESI instruments is highly suitable for molecule fragmentation by 
collision with an inert gas, which can be used to determine the amino acid 
sequence of the peptide from the mass differences of the fragments. Alternative 
cleavage conditions, such as the use of other proteases like proteinase K have 
been described (Wu et al., 2003) and proven superior to trypsin in practice. 
 
One mass spectrometric method for phosphopeptide analysis involves 
detecting the neutral loss of H3PO4 (-98 Da) or HPO3 (-80 Da) from the 
phosphorylated residue (DeGnore and Qin, 1998) by tandem mass spectrometry. 
Another method involves precursor scanning for specific marker ions, such as 
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m/z 63 (PO2-) and 79 (PO3-), in the negative mode, however it makes sequencing 
more difficult; otherwise, there’s the possibility of using skimmer collision-
induced dissociation (CID) (Zolodz and Wood, 2003). 
 
Taking the mass range of common instruments, and the MS/MS and PSD 
capability of ESI and MALDI, respectively, into account, analysis of the probable 
several phosphorylated histatin 1 digests with trypsin, proteinase K and protease 
V8 was carried out to identify the different phosphorylations on histatin 1 by 
detecting the typical neutral losses. 
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4. Research goals 
 
The goals for this research were to identify histatin 1 multiple 
phosphorylation, and relative determination of phosphorylation site using mass 
spectrometry.  
 
Salivary histatins were extracted from whole saliva, followed by their 
separation and identification by HPLC and HPLC-MS. Due to the complexity of the 
peak pattern, each histatin 1 was not completely purified, instead there was a 
colletion of five pools with different composition of the poly-phosphorylated 
peptides. After the HPLC separation, each pool undergoes proteolytic digestion 
and mass peptide mapping to identify and determine the post-translational 
modification. To confirm these assignments, MS/MS and PSD were performed on 
the different pools with the poly-phosphorylated histatins 1 and its proteolytic 
digest fragments. 
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1. Reagents 
  
All common chemicals and reagents were of analytical grade and were 
purchased from Farmitalia-Carlo Erba, (Milan, Italy), Merck (Damstadt, Germany) 
and Sigma Aldrich (St. Louis, MI, USA). Chromatographic eluents were from Carlo 
Erba. 
 
The benzoylated dialysis cellulose membrane with molecular weight cut off 
of 2000 Da was purchased from Sigma Aldrich. Immobilized trypsin and protease 
V8 were obtained from Pierce Biotechnology (Rockford, IL, USA), and proteinase K 
was acquired from Promega (Madison, WI, USA). CHCA matrix and MALDI peptide 
calibration standards were purchased from Bruker Daltonics (Bremen, Germany). 
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2. Apparatus 
 
The HPLC apparatus was a ThermoFinnigan Surveyor Plus (San Jose, USA). 
The HPLC-ESI-IT-MS apparatus was a ThermoFinnigan Surveyor HPLC connected 
by a T splitter to a PDA diode-array detector and to Xcalibur LCQ Deca XP Plus 
mass spectrometer. The mass spectrometer was equipped with an electrospray 
ion (ESI) source.  
 
The chromatographic columns were a Vydac (Hesperia, CA, USA) C8 column 
with 5 μm particle diameter (dimensions 150x2.1 mm) and an Agilent Hypersil 
BDS-C18 column with 3 μm particle diameter (dimensions 100x4.0 mm). MALDI-
TOF-MS was performed using the Autoflex Bruker Daltonics apparatus (Bremen, 
Germany). 
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3. Methods 
 
 
3.1. Sample collection and treatment 
 
Every volunteer had its saliva analyzed and characterized, in order to 
establish it as a standard saliva profile (absent of abnormal peptides). A massive 
preparation of human saliva (500 mL) was done after. The whole human saliva 
was collected in three different days between 10a.m. and 14p.m from seven 
normal adult informed volunteers according to a standard protocol (Castagnola et 
al., 2001). An acidic solution (0.2% TFA) was immediately added to salivary 
samples in an ice bath at a 1:1 v/v ratio and the solution centrifuged at 8000 g 
for 5 min. After centrifugation the supernatant was separated from the 
precipitate. 
 
 
3.2.  Histatins Isolation Using Zinc Precipitation 
  
Zinc chloride was added from a solution 5 mM to the supernantant 
obtained from the treated saliva with the acidic solution to yield a final 
concentration of 500 μM. The pH was subsequently raised to 9.0 with a solution 3 
M NaOH and the sample incubated at 4ºC for 20 minutes. After centrifugation at 
16,000g for 20 minutes, the supernatant was removed and stored at 4ºC. The 
pellet containing different precipitated peptide–metal complexes was washed 
once in the zinc chloride solution.  
Multiple Phosphorylation of Histatin 1 
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Washed pellet was dispersed in distilled water, dissolved by acidifying the 
solution with 3 M HCl and then subjected to dialysis in a benzoylated dialysis 
cellulose membrane with molecular weight cut off of 2000 Da using the buffer 
acetate 30 mM / EDTA 10 mM, pH 5.6.  
 
The dialysis had two days duration and the buffer was changed four times. 
Supernatant was then removed from inside the membrane and lyophilized. 
 
 
3.3. HPLC Purification 
 
The histatins complex in the lyophilized sample obtained through the 
protocol described in section 3.2 was partially purified by chromatographic 
separation. 
The following solutions were utilized for the reversed-phase 
chromatography: (eluent A) 0.056% aqueous TFA and (eluent B) 0.05% TFA in 
acetonitrile-water 80/20 (v/v). The gradient applied arrived to 10% of B in 1 
minute and the was linear from to 37% B in 36 minutes, at a flow rate of 0.90 
mL/min. 
The lyophilized samples were dissolved in 0.2% TFA. Several HPLC analyses 
were done by injecting each time 200 μL. The column eluate was collected in 
fractions. Those containing the various histatins were evaporated to dryness in 
the lyophilizer, taken up in 0.2% TFA, and re-chromatographed in the HPLC-MS in 
order to establish the histatins composition in each different fraction by 
verification of the mass pattern. 
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3.4. Enzymatic Digestion 
 
 
The different compositional histatins fractions collected by RP-HPLC were 
submitted to several digestions and then analyzed by RP-HPLC-ESI and MALDI-
TOF MS. 
 
 
3.4.1. Trypsin 
 
Tryptic digestion was carried out according to the supplier’s instructions 
(Pierce Biotechnology). Briefly, the lyophilized powders from each of the pools 
collected (~30-80 μg) were dissolved into 250 μL of the digestion buffer 
(ammonium bicarbonate 0.1 M, pH 8.0) and incubated at 37ºC for 3 h with 50 μL 
of immobilized trypsin. At the end of digestion, immobilized trypsin was 
separated by centrifugation at 3000g. Each solution was lyophilized, dissolved in 
0.2% TFA and submitted to RP-HPLC-ESI MS and MALDI-TOF-MS analyses. 
 
 
3.4.2. Proteinase K 
 
The digestion with proteinase K was performed under the supplier’s 
instructions (Roche Biochemicals). The lyophilized samples from each fraction 
pool (~30-80 μg) were dissolved into 260 μL of the digestion buffer (TRIS-HCl 50 
mM, pH 8.0, 3 mM CaCl2) and incubated at 56ºC for 3 h with proteinase K at a 
final concentration of 50 μg/ mL. At the end of digestion, proteinase K was 
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inhibited by addition of PMSF (phenylmethylsulfonyl fluoride) at a final 
concentration of 5 mM. Each solution was then lyophilized, dissolved in 0.2% TFA 
and put forward to RPHPLC-ESI MS and MALDI-TOF-MS analyses. 
 
 
3.4.3. Protease V8 
 
The enzymatic digestion with protease V8 was executed following the 
supplier’s instructions (Pierce Biotechnology). The samples from each of the 
collected fractions (~30-80 μg) were dissolved into 160 μL of the digestion buffer 
(buffer 3 from the suppler’s kit; specificity for cleavage at the carboxy terminus 
sides of both glutamic and aspartic acid) and incubated at 37ºC for 7 h with 40 μL 
of immobilized protease V8. At the end of digestion, immobilized enzyme was 
separated by centrifugation at 3000g. Each product solution was lyophilized, 
dissolved in 0.2% TFA and submitted to RP-HPLC-ESI MS and MALDI-TOF-MS 
analyses. 
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3.5. MS Experiments 
 
Each of the different digested fraction pools was submitted to mass 
spectrometric experiments (ESI and MALDI), in order to find out the peptide 
fragments obtained in the enzymatic reactions with trypsin, proteinase K and 
protease V8. All spectra were obtained in the positive ion mode. 
 
 
3.5.1. ESI-MS 
 
The following solutions were utilized for the reversed-phase 
chromatography: (eluent A) 0.056% aqueous TFA and (eluent B) 0.05% TFA in 
acetonitrile-water 80/20 (v/v). The gradient applied was linear from 0 to 55% in 
40 min, at a flow rate of 0.300 mL/min. The T splitter addressed about a flow-
rate of 0.20 ml/min towards the diode array detector and a flow-rate of 0.10 
ml/min towards the ESI source. The diode array detector was usually settled at a 
wavelength of 214-276 nm. Mass spectra were collected every 3 millisecond in 
the positive ion mode. MS spray voltage was 4.50 KV and the capillary 
temperature was 220°C. 
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3.5.2. MALDI-MS 
 
The lyophilized digestion products were purified using ZipTip C18 
micropipet tips following the protocol for desalting/purification provided by the 
manufacturer. The samples dissolved in 0.1% aqueous TFA solution were mixed 
with the CHCA (α-cyano-4-hydroxycinamic acid) matrix solution and deposited 
onto the stainless steel target of the MALDI instrument, according to the dried 
droplet method (Nordhoff et al., 2003). To prepare matrix solutions, saturating 
amount of CHCA was added to acetonitrile:water (33:67, v/v) containing 0.1% 
TFA. Calibration was performed using peptide standard mixture (angiotensin I 
and II, substance P and bombesin). MALDI-TOF mass spectra were acquired with 
a pulsed nitrogen laser (337 nm) in positive, either linear or reflector, mode. In 
linear mode an ion source of 20 kV, a pulsed ion extraction time of 350 ns, a 
detector gain voltage of 1300 V and a laser frequency of 5 Hz were used. In 
positive reflector mode, spectra were obtained with an ion source of 19 kV, a 
pulsed ion extraction time of 150 ns, a detector gain voltage of 1400 V and a 
laser frequency of 5 Hz. About 400 scans were averaged for each spectrum to 
improve signal-to-noise ratio. 
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3.6. Tandem-MS Experiments 
 
Tandem mass spectrometric experiments were done to any ions suspected 
of having the interest modifications to find and verify structural information 
relating to the sequence (and modification itself) of the fragments obtained from 
the digests.  
 
 
3.6.1. ESI-MS/MS 
 
Tandem-MS experiments were performed by detection of parent ions with 
a peak width of 2-4 m/z values with 40-60% of the maximum activation 
amplitude. 
 
 
3.6.2. MALDI-PSD 
 
PSD experiments were realized in the positive-ion mode using the 
segmented approach, where the voltage of the ion reflector is stepped down 
gradually (Spengler, 1991). 
 
After MALDI-MS analysis was done, a peak was time selected and analyzed 
by PSD. The instrument was first calibrated in the normal MALDI mode and then 
in the PSD mode. In addition, the ion selector window must be calibrated to select 
the specific ion of interest for PSD.  
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The PSD acquisition was composed of 19 individual segments that were 
later stitched together by the FAST algorithm. The reflector voltage was varied 
from 19.00 kV to 0.56 kV. The ion ejection voltages at IS1 and IS2 were set to 
18.00 kV and 15.75 kV, respectively, and the lens were set to 7.40 kV. The latter 
three voltages were kept constant throughout the experiment with only the 
reflector voltage being changed for each segment. 
 
 
3.7. Data analysis 
 
Deconvolution of average ESI mass spectra was automatically performed by 
MagTran 1.0 software (Zhang and Marshall, 1998).  Flex control software was 
used for data acquisition and processing of MALDI mass spectra. Experimental 
mass values were compared with average theoretical mass values using the 
PeptideMass program available at the Swiss-Prot (http://us.expasy.org/tools) 
data bank (histatin 1 code: P15515). Mass values determined on the different 
digested samples were compared with the expected average and monoisotopic 
values calculated using the PeptideMass program. Phosphorylation sites were 
deduced by NetPhos program, available at the Center for Biological Sequence 
Analysis (Blom et al., 1999) (http://www.cbs.dtu/dk/services/NetPhos/). 
Generation of theoric MS/MS spectra were performed utilizing the MS-Product 
program, available at the Protein Prospector site (http://prospector.ucsf.edu/). 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
RESULTS AND DISCUSSION 
 
 
Multiple Phosphorylation of Histatin 1 
 
 
1. Sample collection and treatment 
 
The salivary sample pre-treatment with acidic solution caused the 
precipitation of amylases, α-mucins, and other high molecular mass salivary 
proteins. Furthermore, the treatment reduced at a minimum the action of 
endogenous and exogenous salivary proteases and, consequently, the artifact 
occurrence. 
 
All the histatins were soluble in the acidic solution, as it was confirmed by 
an RP-HPLC analysis (Figure 7). 
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 Figure 7 –HPLC-MS spectrum of whole saliva acidic fraction. Upper panel states for the 
total ion current recorded, and the two bottom panels show the UV profile at 214 and 276 
nm. 
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 In the upper panel the profile of total ion current (TIC) recorded by the 
mass spectrometer is reported. During the HPLC separation also the UV profiles 
at 214 and 276 nm were collected. During the first three-five minutes of elution 
the eluent was not addressed towards the ESI-MS apparatus in order to avoid 
damages of the ion-trap mass spectrometer, due to the elevated concentration of 
electrolytes.  
 
In the aim to isolate those pertaining histatin fragments, it was adopted 
the strategy described in the section 3.2 (Oppenheim et al., 1989). 
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2. Histatins Isolation Using Zinc Precipitation 
 
When zinc chloride is added to a final concentration of 500 μM to the 
treated saliva collected and pH raised to 9.0, a white precipitate is formed due to 
the creation of insoluble metal complexes. It contains most of the low molecular 
weight proteins, while the higher molecular weight proteins remain in the 
supernatant. 
 
Oppenheim et al. showed (2001) that this precipitation is zinc dependent 
and not due to a salt effect, although approximately 10% of the histatins remains 
in the supernatant. The complexed histatins are mainly 1, 3, 5 and 6. This metal 
binding property is accredited to the high quantity of histidine, serine, tyrosine 
and aspartic and glutamic acids known to participate in the metal ions 
coordination. Also statherin and PRPs precipitate. 
 
Since PRPs co-elute with some histatins, it was performed a dialysis of the 
acidified solution obtained from the metal complexes precipitate. A new 
precipitate was formed containing the almost all of the undesired PRPs (HPLC-MS 
analysis of the dialysis supernatant showed the presence of PRPs, such as Pb 
peptide and PRP glycosilated derivatives). 
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3. HPLC Purification 
 
During HPLC purification it was detected a peak corresponding to histatin 
1 that also includes the poly-phosphorylated derivatives (non-, mono-, di-, tri-, 
tetra-, and penta-phosphorylated), as revealed by SIM (selected ion monitoring) 
strategy. It’s also perceptible their low quantity (Figure 8). 
 
 
Figure 8 – Chromatographic profile of the different poly-phosphorylated histatins 
1 by means of SIM strategy. 
 
 
In fact, the HPLC purification of the six different poly-phosphorylated 
histatins 1 cannot be fully completed. 
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After different tests, the gradient was chosen, in order to reach a 
satisfactory compromise between peak resolution and analysis time. It was 
obtained, instead of a single peak, a not resolved complex peak that allowed the 
division of it into different pools.  
 
A typical separation obtained on histatins sample is reported in figure 9. 
 
The number of theoretical plates per meter (N/m) on histatin 1 peak was 
maintained trough all the chromatographic analysis, with no changing of the 
guards column, showing that the column performance didn’t decline with the 
used conditions. 
 
Histatin 1 contains in its sequence five tyrosines, being tryptophan absent, 
whereas proline-rich proteins lacking in these aromatic amino acids. Tyrosine 
and tryptophan are the only two amino acids responsible for a sensible protein 
absorbance over 260 nm. Also disulfide bridges absorb at this wavelenght. The 
maximum of tyrosine absorbance is at 272 nm, whereas that of tryptophan is 280 
nm, with a molar extinction coefficient that, under the HPLC conditions used, is 
approximately four-times higher than that of tyrosine. 
 
The PRPs peaks were obviously detectable only at the non-specific 214 nm 
wavelength. Histatins peptides (in particular, the different polyphosphorylated 
histatins 1) were identified on the basis of polarity criteria and by following 
absorbance at 276nm. 
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Since histatin 1 chromatographic peak has complex pattern, it was divided 
into five different pools, which were lyophilized and submitted to HPLC-ESI-MS 
analysis, confirming the molecular mass of these peptides, within the 
experimental error characteristic of this analysis; the poly-phosphorylated 
histatins 1 found in each pool are reported in Table 2 (and figure 9). Analysis on 
the relative abundance showed that histatin 2 (mono-phosphorylated histatin 1) 
was about 10% with respect to histatin 1 and the poly-phosphorylated isoforms 
were all less than 2-3% in normal subjects. The tri- and tetra-phosphorylated 
isoforms were usually the most abundant, whereas the di-phosphorylated and 
the penta-phosphorylated isoforms were often under the detection limit of the 
method. 
 
 
Table 2 – Human salivary poly-phosphorylated histatins 1 detected in the selected 
five pools. 
HPLC Pool Peptides 
I non-, mono-, di-, tri-, tetra- and penta-phosphorylated 
II non-, mono-, di-, tri-, tetra- and penta-phosphorylated 
III non-, mono-, di- and tri-phosphorylated 
IV non-, mono- and di-phosphorylated 
V non- and mono- phosphorylated 
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Figure 9 - Enlargement of the 14.0–39.0 min elution range showing the UV profile (214 
and 276nm) of the HPLC chromatogram. The pools collected are shown. 
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4. Enzymatic Digestion 
 
To confirm the hypothesis of the multiple phosphorylation of histatin 1, all 
pools with partially purified histatins were digested with trypsin, proteinase K and 
protease V8. The resulting digests were then submitted to HPLC-ESI-MS and 
MALDI-TOF analysis. 
 
The theoretical digest masses were calculated considering all the cutting 
possibilities with each enzyme inside the known sequence of histatin 1. It was 
also taking in regard the possible multiple phosphorylations on the residues 
tyrosine and serine in a maximum of five phosphate groups in the fragment 
sequence. 
 
The theoretical fragments were 97 for trypsin, 338 for proteinase K and 
111 for protease V8 digestions. For each of the fragments it was created a layout 
for application in the Xcalibur program in order to facilitate the fragment search 
on the spectra of the digests. 
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5. MS and MS/MS experiments 
 
The efficiency of ionization of phosphopeptides in peptide mixtures is a 
large problem in ESI-MS-based phosphopeptide screening. This inefficiency is 
probably due to competition between peptides, because most of them in an 
enzymatic digest of a phosphoprotein are not phosphopeptides, hence, even 
when they are phosphorylated at a high stoichiometry , they are only minor 
components of the overall mixture and have to compete with all the non-
phosphorylated peptides. Additionally, although having the same sequence, the 
non-phosphorylated and the phosphorylated forms of a given peptide have 
different ionization efficiencies; since the phosphorylated form is more acidic, it 
is less efficiently protonated and as a result less efficiently ionized. Another issue 
of great importance is that cleavage is mainly directed to the weakest linkages, 
resulting on the neutral loss of the phosphate groups instead of the cutting on 
the peptide linkage, making identification and phosphorylation site location very 
challenging. 
 
The peptide fragments were eluted from the column between 5-35 min 
and detected at 214 and 276 nm. After spectra analysis, measured peptide 
fragment masses were compared against theoretical digest masses.  
 
Only those peptides having mass errors within the 90% confidence limit 
were considered as valid matches. Mass shifts related to 98 Da were considered 
as phosphorylation on serine residues. Mass shifts of 80 Da were considered as 
phosphorylation on tyrosine residues (DeGnore and Qin, 1998; Steen et al., 
2006). 
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In this study, only peaks with a relative abundance and a signal-to-noise 
ratio greater than 3 were chosen for data analysis. All m/z data and fragment 
assignments for each peptide detected are provided in the Appendix. 
 
From the 87 fragments found, 36 were phosphorylated. 
 
In view of the complexity of protein digests, a tandem MS step is generally 
required for reliable phosphopeptide identification and is necessary for 
pinpointing of the phosphorylation site(s). The MS/MS experiments performed 
were 57. 
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Figure 10 – MS/MS experiment for m/z 1533.87 (sequence K17-N38). 
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LC/MS/MS analysis of the digests located four phosphorylation sites. For 
example, within a fragment of the C-terminal region of histatin 1 (sequence K17-
N38), being all of the phosphorylations located on the last four tyrosines of the 
sequence: 27, 30, 34 and 36,according with the fact that in the MS/MS spectra of 
the [M+2H+]+2 ion (m/z 1533.87) are visible four neutral losses of 40 Da (80 
Da/2; typical loss of HPO3 from a tyrosine residue), [M-H3PO4+2H+]+2, [M-
2H3PO4+2H+]+2, [M-3H3PO4+2H+]+2, and [M-4H3PO4+2H+]+2, consistent with four 
phosphate groups in the tyrosine residues. Since the fragment considered has 
only four tyrosines in possibility, the sites identification is unequivocally (Figure 
10). The fifth position of the phosphate group would be on Ser-2, as already 
established. The MS/MS experiment of the fragment m/z 829.4 Da (sequence 
D1-R12) support this fact, showing one loss of 98 Da (serine residues usually 
lose H3PO4) consistent with the reported phosphorylation on serine (Figure 11).  
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Figure 11 – MS/MS experiment for m/z 829.4 (sequence D1-R12). 
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Also the PSD experiment sustains the presence of the phosphorylated 
serine on the position 2 (Figure 12). 
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Figure 12 – PSD experiment on m/z 2199.14 (sequence D1-E16, phosphorylated 
on Ser-2). 
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The PSD analysis were not performed on the interest peptide fragments 
with the multiple phosphorylations on the last four tyrosines due to their low 
peak intensity and proximity to other fragment peaks. Instead, it was possible to 
carry it out for certain masses in agreement with phosphorylated fragments in the 
Ser-20 and 32 and Tyr-10. The spectra showed that the masses didn’t 
correspond to the attributed fragment allowing to exclude the possibility of 
phosphorylation on those sites, also because all the digest fragments found 
ranging those residues were non-phosphorylated. 
 
However, the position of these modifications for the di-, tri-, and tetra- 
phosphorylated peptides could not be unambiguously determined, given that 
each pool sample has a complex pattern and, therefore, cannot be said wich 
histatin 1 isoform originates some determined digested phosphorylated 
fragments. 
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6. Theoretical Phosphorylation Prediction 
 
The NetPhos program allows the prediction of the potential 
phosphorylation sites, giving a high score for Ser-20 and lower scores for Ser-2 
and Ser-32. However, all the derivatives of histatin 1, with the exception of 
histatin 2 (mono-phosphorylated histatin 1), are phosphorylated at Ser-2, 
probably by a Golgi (casein-like) kinase not included in NetPhos algorithm, which 
recognizes SX(E/Sphos) as principal consensus sequence (Brunati et al., 2000). 
 
Taking into account the phosphorylation of tyrosine residues, the highest 
scores were obtained for 27, 30 and 36 positions and the lowest for 10 and 34 
positions (Figure 13). 
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Figure 13 –NetPhos 2.0 predicted phosphorylation sites in sequence for histatin 1. 
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MS/MS experiments suggested that the poly-phosphorylation of histatin 1 
involves the four C-terminal tyrosines. Although the score is higher for a serine 
phosphorylation, NetPhos gives a result for the most probable tyrosines involved 
in phosphorylation that is in agreement with the results of this work. 
 
This implies the action of an unknown tyrosine kinase in the secretion 
pathway of histatin 1. 
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CONCLUSIONS 
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The experiments and results presented in this thesis demonstrate 
that mass spectrometry was a useful tool to identify the poly-
phosphorylations of histatin 1. 
 
It was demonstrated that the additional four phosphorylations 
occurring in histatin 1 isoforms, besides the already established on Ser-2, 
are located on the four tyrosines of the C-terminal: Tyr-27, Tyr-30, Tyr-
34, and Tyr-36. Although the determination of all the residues that 
undergo phosphorylation processes was performed, it cannot be affirmed 
unambiguously which of the tyrosine residues are involved in the di-, tri-, 
or tetra-phosphorylated histatins 1. 
 
Further experiments will be necessary to determine with exactitude 
the phosphorylation site on the di-, tri-, and tetra-phosphorylated 
histatins 1. 
 
In future perspectives lies the characterization of the kinase 
responsible for the histatin 1 isoforms phosphorylations, determination of 
histatin 1 function, as well as the evaluation of the different histatin 1 
isoforms profile in individuals, since preliminary data indicated different 
percentages on some pathological samples (Onnis et al., 2005). 
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